These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 10395031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
    Tallman JF, Primus RJ, Brodbeck R, Cornfield L, Meade R, Woodruff K, Ross P, Thurkauf A, Gallager DW.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370
    [Abstract] [Full Text] [Related]

  • 4. NGD 94-1: a specific dopamine-4-receptor antagonist.
    Tallman JF.
    Adv Pharmacol; 1998 Aug; 42():490-2. PubMed ID: 9327946
    [No Abstract] [Full Text] [Related]

  • 5. Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.
    Liégeois JF, Bruhwyler J, Damas J, Rogister F, Masereel B, Geczy J, Delarge J.
    Eur J Pharmacol; 1995 Feb 06; 273(3):R1-3. PubMed ID: 7737323
    [Abstract] [Full Text] [Related]

  • 6. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    Primus RJ, Thurkauf A, Xu J, Yevich E, McInerney S, Shaw K, Tallman JF, Gallagher DW.
    J Pharmacol Exp Ther; 1997 Aug 06; 282(2):1020-7. PubMed ID: 9262371
    [Abstract] [Full Text] [Related]

  • 7. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 06; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
    Kung MP, Stevenson DA, Zhuang ZP, Vessotskie JM, Chumpradit S, Sun XM, Kung HF.
    Life Sci; 1997 Jul 06; 60(2):91-100. PubMed ID: 9000114
    [Abstract] [Full Text] [Related]

  • 9. Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors.
    Watts VJ, Vu MN, Wiens BL, Jovanovic V, Van Tol HH, Neve KA.
    Psychopharmacology (Berl); 1999 Jan 06; 141(1):83-92. PubMed ID: 9952069
    [Abstract] [Full Text] [Related]

  • 10. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
    McAllister G, Knowles MR, Ward-Booth SM, Sinclair HA, Patel S, Marwood R, Emms F, Patel S, Smith A, Seabrook GR.
    J Recept Signal Transduct Res; 1995 Jan 06; 15(1-4):267-81. PubMed ID: 8903944
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study.
    Lahti RA, Roberts RC, Cochrane EV, Primus RJ, Gallager DW, Conley RR, Tamminga CA.
    Mol Psychiatry; 1998 Nov 06; 3(6):528-33. PubMed ID: 9857979
    [Abstract] [Full Text] [Related]

  • 14. 2-Phenyl-4(5)-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]imidazole. A highly selective antagonist at cloned human D4 receptors.
    Thurkauf A, Yuan J, Chen X, He XS, Wasley JW, Hutchison A, Woodruff KH, Meade R, Hoffman DC, Donovan H, Jones-Hertzog DK.
    J Med Chem; 1997 Jan 03; 40(1):1-3. PubMed ID: 9016321
    [No Abstract] [Full Text] [Related]

  • 15. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist.
    Burstein ES, Ma J, Wong S, Gao Y, Pham E, Knapp AE, Nash NR, Olsson R, Davis RE, Hacksell U, Weiner DM, Brann MR.
    J Pharmacol Exp Ther; 2005 Dec 03; 315(3):1278-87. PubMed ID: 16135699
    [Abstract] [Full Text] [Related]

  • 16. PD-168077, a selective dopamine D4 receptor agonist, induces penile erection when injected into the paraventricular nucleus of male rats.
    Melis MR, Succu S, Mascia MS, Argiolas A.
    Neurosci Lett; 2005 Apr 29; 379(1):59-62. PubMed ID: 15814200
    [Abstract] [Full Text] [Related]

  • 17. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C, Carilla-Durand E, Assié MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):135-44. PubMed ID: 16554049
    [Abstract] [Full Text] [Related]

  • 18. A new approach to finding specific dopamine D4 receptor agonists.
    Morishita H, Shibata K, Sakata N, Kita S, Katsuragi T.
    Eur J Pharmacol; 2005 Jun 01; 516(2):145-50. PubMed ID: 15922324
    [Abstract] [Full Text] [Related]

  • 19. Pharmacology of a human dopamine D4 receptor expressed in HEK293 cells.
    Lawson CF, Mortimore RA, Schlachter SK, Smith MW.
    Methods Find Exp Clin Pharmacol; 1994 Jun 01; 16(5):303-7. PubMed ID: 7934308
    [Abstract] [Full Text] [Related]

  • 20. D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia.
    Sharma A, Kramer ML, Wick PF, Liu D, Chari S, Shim S, Tan W, Ouellette D, Nagata M, DuRand CJ, Kotb M, Deth RC.
    Mol Psychiatry; 1999 May 01; 4(3):235-46. PubMed ID: 10395213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.